| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 13,985 | 7,035 | 169,620 | | Cost of Revenue |
-
| 1,619 |
-
| | | Gross Profit | 13,985 | 5,416 | 169,620 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,919 | 1,349 | 2,370 | | Non Recurring | (253) |
-
| (145) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 10,320 | 4,066 | 167,395 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (148,491) | (142,970) |
-
| | Earnings Before Interest And Taxes | 10,320 | 3,826 | 167,855 | | Interest Expense |
-
|
-
| 460 | | Income Before Tax | 10,320 | 3,826 | 167,395 | | Income Tax Expense | 136 | 111 | 53 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (138,307) | (139,014) | 166,881 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (138,307) | (139,014) | 166,881 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($138,307) | ($139,014) | $166,881 |
|
0.29% Nasdaq 
0.64 (0.82%) 
Income Statement
